UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

31 Oct 2008

Transparency Notification of Wellington Management Company LLP

Read More
31 Oct 2008

Fesoterodine approved in the U.S.

Read More
31 Oct 2008

UCB on track

Read More
30 Oct 2008

New Cimzia® study shows rapid reduction of symptoms and progression of rheumatoid arthritis

Read More
29 Oct 2008

UCB's Vimpat® approved by U.S. FDA as adjunctive therapy for partial onset seizures in adults

Read More
25 Sep 2008

UCB withdraws EU marketing authorisation application for lacosamide in diabetic neuropathic pain

Read More

Stay up-to-date on the latest news and information from UCB